For a mega-cap technology stock that investors generally expect to outperform the market, this is quite a letdown.
The Clear Aligner Material Market reached a valuation of USD 3.5 billion in 2024, reflecting strong adoption across dental clinics and orthodontic practices worldwide. Supported by increasing patient ...
Zetler claims in his affidavit dated 21.11.2025 stated in para 8.1.2: ‘I contacted Mr Isaac Benatar of Numus and advised him telephonically that Novus wanted to acquire CFDs…’ 7 See also Affidavit ...
Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.